Pragmatic Trial of Messaging to Providers About Treatment of Chronic Kidney Disease

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT07430930
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chronic Kidney Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Best practice alert and order set for CKD — OTHER
    Providers are exposed to a best practice alert upon opening of the order entry screen in a patient's medical record. The alert informs the provider of the presence of CKD, details the patient's current relevant labs and medications, and provides a list of recommended indicated GDMT for CKD which the patient is currently not prescribed. The alert includes an order set with all indicated medications with additional prescribing information. The alerts additionally includes a link to updated guidelines for GDMT prescription for CKD. Providers will be given the option to dismiss the alert and to indicate reasons for dismissing.

Study Details

This study is a cluster-randomized clinical trial to evaluate whether a tailored, user-centered, clinical decision support (CDS) tool can positively influence prescriber behavior and increase prescription of guideline-directed medical therapy (GDMT) among patients with Chronic Kidney Disease (CKD) across a single healthcare center.

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Sep 30, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
1,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Exposure to clinical decision support tool
    Providers will see a best practice alert with an attached order set upon opening the order entry screen in an eligible patient's medical record.
  • No Intervention: Usual Care
    Providers will not be exposed to the clinical decision support tool when in the medical record of an eligible patient.

Primary Outcome Measure

New GDMT prescription within 90 days [ Time Frame: Up to 90 days of randomization ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Yale New Haven HealthNew HavenConnecticut06520-

Find similar trials in New Haven, CT

By research site
Yale New Haven Health· New Haven, CT

Related Studies